Revenio Group Oyj (LTS:0KFH) FFO


LTS:0KFH Revenio Group Oyj LTS:0KFH
74 GF Score
Price €12.20
GF Value €30.37
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Revenio Group Oyj FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0KFH
74GF Score
Revenio Group Oyj LTS:0KFH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Revenio Group Oyj (LTS:0KFH) Overvalued in 2026?

Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued. The current stock price of €12.20 is trading 59.8% below its estimated GF Value™ of €30.37. GuruFocus considers Revenio Group Oyj to be Significantly Undervalued.

Key valuation signals for LTS:0KFH:

  • FFO:
  • GF Value™: €30.37 vs. price of €12.20 (59.8% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the LTS:0KFH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Revenio Group Oyj Business Description

Address Harkahaankuja 7, Vantaa, FIN, 01730
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
74GF Score

Get the complete analysis for LTS:0KFH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.20
Price
€30.37
GF Value